214 related articles for article (PubMed ID: 10958084)
21. Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats.
Ahlenius S; Ericson E
J Neural Transm (Vienna); 2001; 108(4):415-30. PubMed ID: 11475009
[TBL] [Abstract][Full Text] [Related]
22. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
Linnér L; Wiker C; Wadenberg ML; Schalling M; Svensson TH
Neuropsychopharmacology; 2002 Nov; 27(5):691-8. PubMed ID: 12431844
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of dopamine D1 and D2 receptor antagonists on conditioned orienting behavior in the rat.
Chang YH; Liao RM
Chin J Physiol; 2003 Dec; 46(4):159-68. PubMed ID: 15074836
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
Ozer H; Ekinci AC; Starr MS
Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
[TBL] [Abstract][Full Text] [Related]
25. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
Anderson JJ; Kask AM; Chase TN
Eur J Pharmacol; 1996 Jan; 295(2-3):163-8. PubMed ID: 8720580
[TBL] [Abstract][Full Text] [Related]
26. Relation between cortical dopamine D(2) receptor occupancy and suppression of conditioned avoidance response in non-human primate.
Takano A; Suhara T; Maeda J; Ando K; Okauchi T; Obayashi S; Nakayama T; Kapur S
Psychiatry Clin Neurosci; 2004 Jun; 58(3):330-2. PubMed ID: 15149302
[TBL] [Abstract][Full Text] [Related]
27. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
28. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
Papa SM; Engber TM; Boldry RC; Chase TN
Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
[TBL] [Abstract][Full Text] [Related]
29. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
[TBL] [Abstract][Full Text] [Related]
31. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Wadenberg ML; Wiker C; Svensson TH
Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
[TBL] [Abstract][Full Text] [Related]
32. Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.
Eltayb A; Wadenberg ML; Schilström B; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):195-202. PubMed ID: 16284783
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.
Wadenberg ML; Hicks PB; Richter JT; Young KA
Biol Psychiatry; 1998 Sep; 44(6):508-15. PubMed ID: 9777184
[TBL] [Abstract][Full Text] [Related]
34. Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists.
Niu M; Kasai A; Seiriki K; Hayashida M; Tanuma M; Yokoyama R; Hirato Y; Hashimoto H
Biol Pharm Bull; 2021; 44(3):442-447. PubMed ID: 33642553
[TBL] [Abstract][Full Text] [Related]
35. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
36. Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ.
Kapur S; Barsoum SC; Seeman P
Neuropsychopharmacology; 2000 Nov; 23(5):595-8. PubMed ID: 11027926
[TBL] [Abstract][Full Text] [Related]
37. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
38. The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat.
Natesan S; Svensson KA; Reckless GE; Nobrega JN; Barlow KB; Johansson AM; Kapur S
J Pharmacol Exp Ther; 2006 Aug; 318(2):810-8. PubMed ID: 16648369
[TBL] [Abstract][Full Text] [Related]
39. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
Parashos SA; Marin C; Chase TN
Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
[TBL] [Abstract][Full Text] [Related]
40. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
